NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
NEUROONE MEDICAL TECHNOLOGIES Corp
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.00+0.04 (+4.01%)
Close on Oct 19, 2026
- Market cap
- $8.74M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.95 (−79.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
NEUROONE MEDICAL TECHNOLOGIES Corp grew revenue 42.8% to $9.47M over the twelve months to Jun 30, 2026. Free cash flow was -$7.16M.
Revenue
$9.47M
+42.8% vs. a year earlier
Operating income
-$7.90M
TTM Q3 2026
Free cash flow
-$7.16M
TTM Q3 2026
EPS, diluted
-$0.93
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $8.74M
- P/E ratio
- –
- Price to sales
- 0.92
- Price to book
- 2.32
- Dividend yield
- –
- Free cash flow yield
- -81.94%
Fundamentals
- Revenue
- $9.47M
- Net income
- -$7.45M
- EPS, diluted
- -$0.93
- Free cash flow
- -$7.16M
- Book value per share
- $0.43
- Diluted shares
- 9M
Fifteen years at a glance
Fiscal years 2009 to 2025 and trailing twelve months, USD
Revenue
$9.47M+42.8% YoY
Gross profit
$5.27M+40.4% YoY
Operating income
-$7.90M
Net income
-$7.45M
EPS, diluted
-$0.93
Free cash flow
-$7.16M
Reported periodTrailing twelve months